Schrödinger’s Post

Interested in implementing an effective multi-scale simulation framework to study key properties of composites? Join us at this year’s Composites and Advanced Materials Expo (CAMX) on Sept 9-12th. • Don’t miss the talk by Schrödinger’s Andrea Browning on Sept 10th to hear real-world case studies exploring efficient computational approaches for materials product design without requiring experimentation or testing. • Check out the panel discussion on Sept 10th to learn how AI-driven innovations can shape the future of materials development. • Stop by our booth G33 to speak with our experts and catch a live demo on Sept 11th highlighting how digital simulation can accelerate your R&D. Learn more: https://hubs.li/Q02MLmmL0 #Schrodinger #MaterialsScience #DigitalChemistry #Polymers

Schrödinger will be closed August 19-23 for Project R&R — a week for our employees to rest and recharge with family and friends.

A smart, strategic drug formulation can efficiently advance your drug development projects and inform downstream processes. Cutting-edge molecular modeling and machine learning are enabling atomistic-level insights and the ability to evaluate large numbers of candidate materials and formulations prior to experiments. Join us on Wednesdays this fall for Schrödinger’s Computationally-Guided Drug Formulation Webinar Series – five webinars in which we will explore how the latest computational modeling tools are impacting the pharmaceutical formulation process. Register here: https://lnkd.in/ggg-WkN6

Schrödinger is pleased to share our recent coverage by Alex Philippidis, released yesterday and available now on Genetic Engineering & Biotechnology News.

Schrödinger is excited to be participating in the EFMC International Symposium on Medicinal Chemistry taking place on September 1st – 5th in Rome, Italy. Join us for a presentation and workshop by Schrödinger scientists. Learn more: https://hubs.li/Q02KjVX80

At Schrödinger, we are continuously improving our platform through rigorous scientific advancement. Check out the new features and usability improvements in Schrödinger’s 2024-3 software release: https://lnkd.in/eYix7f2C

Schrödinger will announce second quarter 2024 financial results today, July 31, 2024 at 4:30 PM ET. Listen to the LIVE webcast here: https://lnkd.in/d3baFfsM

Schrödinger is excited to be participating in the 8th International Conference on Vibrational Optical Activity taking place August 4-8 in Bochum, Germany. Join us for a presentation by Art Bochevarov, Research Leader at Schrödinger, in which he will discuss the latest tools and algorithms Schrödinger has developed to aid in the selection of conformers for VCD spectra prediction, including Jaguar Spectroscopy. Learn more: https://hubs.li/Q02Jk6xY0

Today, Schrödinger announced a new initiative leveraging our computational platform to predict toxicology risk early in drug discovery. Initially funded by a $10 million grant from the Bill & Melinda Gates Foundation and enabled by NVIDIA’s AI technologies, the initiative aims to improve properties of novel drug development candidates and reduce their risk of binding to off-target proteins, which can be associated with serious side effects and lead to failure of the development program. Learn more about the new initiative in our press release: https://hubs.li/Q02J2Nmq0

AI/ML models are powerful tools for predicting diverse physical and chemical properties of small molecules. However, fine-tuning these models is resource-intensive and challenging to scale for numerous, frequently updated datasets. Join us on August 13th for a webinar introducing Schrödinger’s LiveDesign Learning, a new module in LiveDesign for training and deploying state-of-the-art AI/ML models with minimal manual intervention to offer rapid molecular property predictions. Register now: https://lnkd.in/g6QMpEkg